OptimizeRx Corporation Common Stock
OPRX US68401U2042
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 86% | -73% | -16% | -65% | 5% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Silvestro Stephen L CEO |
18.75 USD |
1,620 Sold |
30,375 USD |
03/10/2025 | 03/10/2025 |
| Spangler Patrick D O |
17.49 USD |
11,120 Sold |
194,489 USD |
28/08/2025 | 28/08/2025 |
| Lang James Paul O |
7.60 USD |
321,408 Bought |
2,443,761 USD |
14/03/2025 | 14/03/2025 |
| Febbo William J CEO |
5.01 USD |
20,000 Bought |
100,220 USD |
12/12/2024 | 12/12/2024 |
| Odence-ford Marion CCO |
15.19 USD |
4,000 Sold |
60,751 USD |
09/01/2024 | 09/01/2024 |